DA-1726
First in Human Study in Subjects With Obesity, But Otherwise Healthy
NeuroBo Pharmaceuticals Inc · Phase 1 · Recruiting · Enrollment 139
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Part 1 - Single Ascending Dose | n/r | n/r | n/r | n/r |
| Part 2 - Multiple Ascending Dose | n/r | n/r | n/r | n/r |
| Part 3 - Titration | n/r | n/r | n/r | n/r |
Not shown
- Part 1 - Single Ascending Dose: endpoint not reported
- Part 2 - Multiple Ascending Dose: endpoint not reported
- Part 3 - Titration: endpoint not reported